Inspira Technologies OXY B.H.N. (IINN) Competitors

$0.73 +0.42 (+140.01%)

As of 05/22/2026

IINN vs. ECOR, NSPR, NTRB, PSTV, and NEPH

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? MarketBeat compares Inspira Technologies OXY B.H.N. with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspira Technologies OXY B.H.N. include electroCore (ECOR), InspireMD (NSPR), Nutriband (NTRB), Plus Therapeutics (PSTV), and Nephros (NEPH). These companies are all part of the "medical equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to electroCore?

electroCore (NASDAQ:ECOR) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

26.7% of electroCore shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 13.8% of electroCore shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

electroCore has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its share price is 116% more volatile than the broader market.

electroCore presently has a consensus price target of $18.00, indicating a potential upside of 169.87%. Inspira Technologies OXY B.H.N. has a consensus price target of $2.00, indicating a potential upside of 175.10%. Given Inspira Technologies OXY B.H.N.'s higher probable upside, analysts clearly believe Inspira Technologies OXY B.H.N. is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to electroCore's net margin of -44.08%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-44.08%	-1,956.38%	-83.30%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

In the previous week, electroCore had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for electroCore and 2 mentions for Inspira Technologies OXY B.H.N.. electroCore's average media sentiment score of 0.69 beat Inspira Technologies OXY B.H.N.'s score of 0.40 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than electroCore.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	1.73	-$13.97M	-$1.77	N/A
Inspira Technologies OXY B.H.N.	$289K	90.43	-$13.22M	N/A	N/A

Summary

Inspira Technologies OXY B.H.N. beats electroCore on 8 of the 12 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to InspireMD?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Inspira Technologies OXY B.H.N. currently has a consensus price target of $2.00, suggesting a potential upside of 175.10%. InspireMD has a consensus price target of $4.50, suggesting a potential upside of 350.00%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 34.1% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
InspireMD	-413.96%	-69.42%	-57.68%

In the previous week, InspireMD had 14 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 16 mentions for InspireMD and 2 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.40 beat InspireMD's score of -0.69 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InspireMD	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than InspireMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$289K	90.43	-$13.22M	N/A	N/A
InspireMD	$10.85M	4.32	-$19.92M	-$0.73	N/A

Summary

Inspira Technologies OXY B.H.N. and InspireMD tied by winning 7 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Nutriband?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Nutriband's net margin of -403.98%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Nutriband	-403.98%	-118.33%	-101.92%

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 19.7% of Nutriband shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 52.2% of Nutriband shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market. Comparatively, Nutriband has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market.

Nutriband has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$289K	90.43	-$13.22M	N/A	N/A
Nutriband	$2.04M	21.70	-$8.23M	-$2.60	N/A

Inspira Technologies OXY B.H.N. currently has a consensus price target of $2.00, suggesting a potential upside of 175.10%. Given Inspira Technologies OXY B.H.N.'s stronger consensus rating and higher probable upside, equities analysts plainly believe Inspira Technologies OXY B.H.N. is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Nutriband. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 0 mentions for Nutriband. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.40 beat Nutriband's score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Neutral
Nutriband	Neutral

Summary

Inspira Technologies OXY B.H.N. beats Nutriband on 10 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Plus Therapeutics?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Plus Therapeutics (NASDAQ:PSTV) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Plus Therapeutics' net margin of -230.24%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Plus Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Plus Therapeutics	-230.24%	-198.48%	-73.13%

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 3.3% of Plus Therapeutics shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 2.5% of Plus Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market. Comparatively, Plus Therapeutics has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

Inspira Technologies OXY B.H.N. currently has a consensus target price of $2.00, indicating a potential upside of 175.10%. Plus Therapeutics has a consensus target price of $58.00, indicating a potential upside of 780.12%. Given Plus Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Plus Therapeutics is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Plus Therapeutics	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Plus Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$289K	90.43	-$13.22M	N/A	N/A
Plus Therapeutics	$5.21M	8.70	-$22.39M	-$2.30	N/A

In the previous week, Plus Therapeutics had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for Plus Therapeutics and 2 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.40 beat Plus Therapeutics' score of 0.19 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Plus Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Inspira Technologies OXY B.H.N. beats Plus Therapeutics on 9 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Nephros?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Nephros (NASDAQ:NEPH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 41.1% of Nephros shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Comparatively, 6.7% of Nephros shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Nephros has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$289K	90.43	-$13.22M	N/A	N/A
Nephros	$18.79M	2.01	$1.19M	$0.07	49.57

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Nephros. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 0 mentions for Nephros. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.40 beat Nephros' score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Neutral
Nephros	Neutral

Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market. Comparatively, Nephros has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market.

Nephros has a net margin of 4.06% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Nephros' return on equity of 7.66% beat Inspira Technologies OXY B.H.N.'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Nephros	4.06%	7.66%	5.86%

Inspira Technologies OXY B.H.N. currently has a consensus target price of $2.00, suggesting a potential upside of 175.10%. Nephros has a consensus target price of $6.00, suggesting a potential upside of 72.91%. Given Inspira Technologies OXY B.H.N.'s higher possible upside, research analysts plainly believe Inspira Technologies OXY B.H.N. is more favorable than Nephros.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nephros	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Nephros beats Inspira Technologies OXY B.H.N. on 7 of the 13 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IINN vs. The Competition

Export

Metric	Inspira Technologies OXY B.H.N.	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$26.14M	$7.10B	$6.46B	$12.34B
Dividend Yield	N/A	1.68%	2.76%	5.28%
P/E Ratio	N/A	47.45	21.21	25.65
Price / Sales	90.43	73.72	554.38	86.31
Price / Cash	N/A	24.91	43.49	56.67
Price / Book	12.12	6.53	10.37	7.14
Net Income	-$13.22M	$158.81M	$3.57B	$335.98M
7 Day Performance	91.32%	3.61%	6.40%	4.15%
1 Month Performance	35.84%	0.74%	3.53%	2.54%
1 Year Performance	53.05%	3.17%	34.04%	35.06%

Inspira Technologies OXY B.H.N. Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IINN Inspira Technologies OXY B.H.N.	1.9719 of 5 stars	$0.73 +140.0%	$2.00 +175.1%	+53.1%	$26.14M	$289K	N/A	20	Gap Up High Trading Volume
ECOR electroCore	2.9269 of 5 stars	$6.13 +3.7%	$18.00 +193.6%	+34.2%	$48.99M	$32.03M	N/A	50
NSPR InspireMD	3.6117 of 5 stars	$1.00 flat	$4.50 +350.0%	-60.5%	$46.84M	$10.85M	N/A	50	Gap Up
NTRB Nutriband	0.2217 of 5 stars	$3.53 +2.3%	N/A	-33.6%	$41.94M	$2.04M	N/A	10	Upcoming Earnings
PSTV Plus Therapeutics	2.5964 of 5 stars	$6.43 +10.3%	$58.00 +802.0%	-11.8%	$40.13M	$5.21M	N/A	20	Upcoming Earnings Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IINN) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inspira Technologies OXY B.H.N. (IINN) Competitors

IINN vs. ECOR, NSPR, NTRB, PSTV, and NEPH

How does Inspira Technologies OXY B.H.N. compare to electroCore?

Summary

How does Inspira Technologies OXY B.H.N. compare to InspireMD?

Summary

How does Inspira Technologies OXY B.H.N. compare to Nutriband?

Summary

How does Inspira Technologies OXY B.H.N. compare to Plus Therapeutics?

Summary

How does Inspira Technologies OXY B.H.N. compare to Nephros?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IINN vs. The Competition

Inspira Technologies OXY B.H.N. Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inspira Technologies OXY B.H.N. (IINN) Competitors

IINN vs. ECOR, NSPR, NTRB, PSTV, and NEPH

How does Inspira Technologies OXY B.H.N. compare to electroCore?

Do insiders & institutionals believe in ECOR or IINN?

Which has more risk and volatility, ECOR or IINN?

Do analysts prefer ECOR or IINN?

Is ECOR or IINN more profitable?

Does the media refer more to ECOR or IINN?

Which has better valuation and earnings, ECOR or IINN?

Summary

How does Inspira Technologies OXY B.H.N. compare to InspireMD?

Do analysts prefer IINN or NSPR?

Do insiders & institutionals hold more shares of IINN or NSPR?

Is IINN or NSPR more profitable?

Does the media favor IINN or NSPR?

Which has more volatility & risk, IINN or NSPR?

Which has better valuation & earnings, IINN or NSPR?

Summary

How does Inspira Technologies OXY B.H.N. compare to Nutriband?

Is IINN or NTRB more profitable?

Do insiders and institutionals hold more shares of IINN or NTRB?

Which has more volatility & risk, IINN or NTRB?

Which has better valuation and earnings, IINN or NTRB?

Do analysts recommend IINN or NTRB?

Does the media favor IINN or NTRB?

Summary

How does Inspira Technologies OXY B.H.N. compare to Plus Therapeutics?

Is IINN or PSTV more profitable?

Do institutionals & insiders believe in IINN or PSTV?

Which has more risk & volatility, IINN or PSTV?

Do analysts rate IINN or PSTV?

Which has better valuation and earnings, IINN or PSTV?

Does the media favor IINN or PSTV?

Summary

How does Inspira Technologies OXY B.H.N. compare to Nephros?

Do insiders and institutionals have more ownership in IINN or NEPH?

Which has better earnings & valuation, IINN or NEPH?

Does the media prefer IINN or NEPH?

Which has more risk & volatility, IINN or NEPH?

Is IINN or NEPH more profitable?

Do analysts prefer IINN or NEPH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IINN vs. The Competition

Inspira Technologies OXY B.H.N. Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools